722 results on '"Mitani, Kinuko"'
Search Results
2. Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016–2021)
3. Characteristics and prognosis of patients with COVID-19 and hematological diseases in Japan: a cross-sectional study
4. Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis
5. Progression to B acute lymphoblastic leukemia in 8p11 myeloproliferative syndrome with t(6;8)(q27;p12)
6. Nationwide prospective survey of secondary myelofibrosis in Japan: superiority of DIPSS-plus to MYSEC-PM as a survival risk model
7. Prognostic factors for the development of lower respiratory tract infection after influenza virus infection in allogeneic hematopoietic stem cell transplantation recipients: A Kanto Study Group for Cell Therapy multicenter analysis
8. ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial
9. Incidence of acquired pure red cell aplasia: a nationwide epidemiologic analysis with 2 registry databases in Japan
10. Development of Philadelphia chromosome-negative acute myeloid leukemia with IDH2 and NPM1 mutations in a patient with chronic myeloid leukemia who showed a major molecular response to tyrosine kinase inhibitor therapy
11. Continuous lenalidomide treatment after bortezomib-melphalan-prednisolone therapy for newly diagnosed multiple myeloma
12. Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia
13. A case report of secondary neurolymphomatosis showing selective nerve infiltration and massive lumbar plexus enlargement
14. Clonal hematopoiesis in adult pure red cell aplasia
15. Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study
16. Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis
17. RUNX1-EVI1 induces dysplastic hematopoiesis and acute leukemia of the megakaryocytic lineage in mice
18. Interobserver concordance of assessments of dysplasia and blast counts for the diagnosis of patients with cytopenia: From the Japanese central review study
19. Serum ferritin levels at diagnosis predict prognosis in patients with low blast count myelodysplastic syndromes
20. P777: EFFICACY AND SAFETY OF ROMIPLOSTIM COMBINED WITH CYCLOSPORINE A AS A FIRST-LINE TREATMENT IN PATIENTS WITH APLASTIC ANEMIA: A PHASE 2/3 CLINICAL TRIAL.
21. Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study
22. Switching to nilotinib is associated with deeper molecular responses in chronic myeloid leukemia chronic phase with major molecular responses to imatinib: STAT1 trial in Japan
23. Clinical and prognostic features of Langerhans cell histiocytosis in adults
24. Clonal hematopoiesis in adult pure red cell aplasia
25. 2) Cancer-associated Thrombosis～Current Status and Challenges～
26. Clinical utility of Todai OncoPanel in the setting of approved comprehensive cancer genomic profiling tests in Japan
27. Validation of the revised International Prognostic Scoring System in patients with myelodysplastic syndrome in Japan: results from a prospective multicenter registry
28. DNAM-1/Tigit/CD155/CD112 Axis Is a Novel Target of NK-Cell Therapy in Acute Myeloid Leukemia
29. Efficacy and Safety of Long-Term Romiplostim Use for Refractory Aplastic Anemia
30. Chronic myelogenous leukemia in chronic phase transforming into acute leukemia under treatment with dasatinib 4 months after diagnosis
31. CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21)
32. A randomized controlled trial comparing darbepoetin alfa doses in red blood cell transfusion-dependent patients with low- or intermediate-1 risk myelodysplastic syndromes
33. Differences in blast immunophenotypes among disease types in myelodysplastic syndromes: A multicenter validation study
34. Transcriptional Activation of the Human Heme Oxygenase-1 Gene during Acute-Phase Reaction
35. Emergence of t(3;21)(q26.2;q22) during eltrombopag treatment in a patient with relapsed aplastic anemia who received chemotherapy for angioimmunoblastic T-cell lymphoma
36. P1-255 - Non-Hodgkin's lymphoma of the breast: a review of 6 cases including 3 patients with a history of autoimmune diseases
37. Expressional changes of genes and miRNA in common megakaryocyte-erythroid progenitors from lower-risk myelodysplastic syndrome
38. Prednisone versus high-dose dexamethasone for untreated primary immune thrombocytopenia. A retrospective study of the Japan Hematology & Oncology Clinical Study Group
39. A case of pulmonary mucosa-associated lymphoid tissue lymphoma diagnosed by detecting t(11;18)(q21;q21) in bronchial lavage fluid
40. Multicenter phase II trial of vitamin K 2 monotherapy and vitamin K 2 plus 1α-hydroxyvitamin D 3 combination therapy for low-risk myelodysplastic syndromes
41. ASXL1 Mutations with Serum EPO Levels Predict a Poor Response to Darbepoetin Alfa in Lower-Risk MDS: W-JHS MDS01 Trial
42. A Nationwide Survey of Lower Risk Myelodysplastic Syndromes in Japan
43. Suicide attempt induced by drug‐induced leukoencephalopathy: A case report
44. Fadd and Skp2 are possible downstream targets of RUNX1-EVI1
45. Additional file 1 of A case report of secondary neurolymphomatosis showing selective nerve infiltration and massive lumbar plexus enlargement
46. Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia
47. Intensive chemotherapy for elderly patients with acute myelogeneous leukemia: a propensity score analysis by the Japan Hematology and Oncology Clinical Study Group (J-HOCS)
48. Acute myeloid leukemia with t(7;21)(q11.2;q22) expresses a novel, reversed-sequence RUNX1–DTX2 chimera
49. Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia: results of the JALSG AML97 study
50. Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia: final results of Japanese multicenter cooperative study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.